|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.070 USD | -4.20% |
|
+46.07% | +221.36% |
| Dec. 09 | Immix Biopharma announces closing of upsized $100 million underwritten offering of common stock and pre-funded warrants | RE |
| Dec. 08 | Immix Biopharma Prices $100 Million Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 248M | - | - | - | - | - |
| 54.44B | |||||
| 41.64B | - | ||||
| 39.35B | |||||
| 23.08B | - | ||||
| 19.82B |
Select your edition
All financial news and data tailored to specific country editions
